Hassan Fred 4

What Happened

• Hassan Fred, a director of Precigen, had 71,839 restricted stock units (RSUs) vest in full on March 13, 2026. Those RSUs converted into 71,839 shares of Precigen common stock (reported as an exercise/conversion of a derivative, code M).
• The filing also reports a simultaneous disposition of 71,839 shares at a $0.00 price (no cash proceeds reported). Footnotes state that each RSU represents the right to one share and that the RSUs vested in full on March 13, 2026.

Key Details

• Transaction date: March 13, 2026 (reported on Form 4 filed March 16, 2026).
• Transactions reported: 71,839 shares acquired by conversion of RSUs; 71,839 shares disposed at $0.00.
• Price/value: Acquired at N/A (conversion); disposed at $0.00 — no cash proceeds shown.
• Footnotes: F1 — each RSU = one share; F2 — RSUs vested in full on 3/13/2026.
• Shares owned after transaction: Not reported in the provided filing excerpt.
• Timeliness: Form 4 filed March 16 for a March 13 transaction (filed within the typical two-business-day reporting window).

Context

• This appears to be a standard vesting/conversion of RSU compensation rather than a market purchase or sale by the insider. The zero-dollar disposition often reflects share transfers to cover tax withholding or similar administrative mechanics, but the filing does not explicitly state the reason. Such transactions are routine compensation events and do not necessarily signal a change in insider sentiment.